These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 25985145)

  • 1. Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction.
    Su Q; Nyi TS; Li L
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD009503. PubMed ID: 25985145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction.
    Aung Naing K; Li L; Su Q; Wu T
    Cochrane Database Syst Rev; 2013 Jun; (6):CD009503. PubMed ID: 23736949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis.
    Niu X; Zhang J; Bai M; Peng Y; Sun S; Zhang Z
    BMC Cardiovasc Disord; 2018 Jan; 18(1):3. PubMed ID: 29320987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-blockers for suspected or diagnosed acute myocardial infarction.
    Safi S; Sethi NJ; Nielsen EE; Feinberg J; Jakobsen JC; Gluud C
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012484. PubMed ID: 31845756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Adenosine in Patients With Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A PRISMA-Compliant Meta-Analysis.
    Gao Q; Yang B; Guo Y; Zheng F
    Medicine (Baltimore); 2015 Aug; 94(32):e1279. PubMed ID: 26266362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete versus culprit-only revascularisation in ST elevation myocardial infarction with multi-vessel disease.
    Bravo CA; Hirji SA; Bhatt DL; Kataria R; Faxon DP; Ohman EM; Anderson KL; Sidi AI; Sketch MH; Zarich SW; Osho AA; Gluud C; Kelbæk H; Engstrøm T; Høfsten DE; Brennan JM
    Cochrane Database Syst Rev; 2017 May; 5(5):CD011986. PubMed ID: 28470696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of verapamil and adenosine in an adjunct to tirofiban on resolution and prognosis of noreflow phenomenon in patients with acute myocardial infarction.
    Faruk Akturk I; Arif Yalcin A; Biyik I; Sarikamis C; Turhan Caglar N; Erturk M; Celik O; Uzun F; Murat Caglar I; Oner E
    Minerva Cardioangiol; 2014 Oct; 62(5):389-97. PubMed ID: 24699550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intracoronary nitroprusside in preventing no reflow phenomenon during primary percutaneous coronary intervention: a meta-analysis.
    Zhao S; Qi G; Tian W; Chen L; Sun Y
    J Interv Cardiol; 2014 Aug; 27(4):356-64. PubMed ID: 25041036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of monocyte chemoattractant protein-1 to predict no-reflow and three-year mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Buyukkaya E; Poyraz F; Karakas MF; Kurt M; Akcay AB; Akpinar I; Motor S; Turak O; Ozturk OH; Sen N; Akpek M; Kaya MG; Gibson CM
    Am J Cardiol; 2013 Jul; 112(2):187-93. PubMed ID: 23601576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verapamil reverses myocardial no-reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction.
    Fu Q; Lu W; Huang YJ; Wu Q; Wang LG; Wang HB; Jiang SZ; Wang YJ
    Cell Biochem Biophys; 2013; 67(3):911-4. PubMed ID: 23559273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term effect of verapamil on coronary no-reflow associated with percutaneous coronary intervention in patients with acute coronary syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Su Q; Li L; Liu Y
    Clin Cardiol; 2013 Aug; 36(8):E11-6. PubMed ID: 23749333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-eluting stents versus bare-metal stents for acute coronary syndrome.
    Feinberg J; Nielsen EE; Greenhalgh J; Hounsome J; Sethi NJ; Safi S; Gluud C; Jakobsen JC
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012481. PubMed ID: 28832903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic lidocaine for myocardial infarction.
    Martí-Carvajal AJ; Simancas-Racines D; Anand V; Bangdiwala S
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD008553. PubMed ID: 26295202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracoronary adenosine compared with adrenaline and verapamil in the treatment of no-reflow phenomenon following primary PCI in STEMI patients.
    Abu Arab T; Sedhom R; Gomaa Y; El Etriby A
    Int J Cardiol; 2024 Sep; 410():132228. PubMed ID: 38844092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.
    Uhlig K; Efremov L; Tongers J; Frantz S; Mikolajczyk R; Sedding D; Schumann J
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD009669. PubMed ID: 33152122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials.
    Singh M; Shah T; Khosla K; Singh P; Molnar J; Khosla S; Arora R
    Ther Adv Cardiovasc Dis; 2012 Jun; 6(3):101-14. PubMed ID: 22562999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipyridamole versus verapamil for treatment of no-reflow during primary angioplasty.
    Tanzilli G; Greco C; Pasceri V; Pelliccia F; Arrivi A; Placanica A; Mangieri E
    Catheter Cardiovasc Interv; 2010 Nov; 76(6):787-93. PubMed ID: 20737584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Routine invasive strategies versus selective invasive strategies for unstable angina and non-ST elevation myocardial infarction in the stent era.
    Fanning JP; Nyong J; Scott IA; Aroney CN; Walters DL
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD004815. PubMed ID: 27226069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative beta-blockers for preventing surgery-related mortality and morbidity.
    Blessberger H; Kammler J; Domanovits H; Schlager O; Wildner B; Azar D; Schillinger M; Wiesbauer F; Steinwender C
    Cochrane Database Syst Rev; 2014 Sep; (9):CD004476. PubMed ID: 25233038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.